ES2195752B1 - Procedimiento para la preparacion de polimorfos cristalinos de la sal sodica del fosinopril. - Google Patents

Procedimiento para la preparacion de polimorfos cristalinos de la sal sodica del fosinopril.

Info

Publication number
ES2195752B1
ES2195752B1 ES200102739A ES200102739A ES2195752B1 ES 2195752 B1 ES2195752 B1 ES 2195752B1 ES 200102739 A ES200102739 A ES 200102739A ES 200102739 A ES200102739 A ES 200102739A ES 2195752 B1 ES2195752 B1 ES 2195752B1
Authority
ES
Spain
Prior art keywords
procedure
fosinopril
crystalline
preparation
polymorphes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200102739A
Other languages
English (en)
Other versions
ES2195752A1 (es
Inventor
Antonio Luis Palomo Coll
Sandra Gallego Pato
Francisco Palomo Nicolau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quimica Sintetica SA
Original Assignee
Quimica Sintetica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200102739A priority Critical patent/ES2195752B1/es
Application filed by Quimica Sintetica SA filed Critical Quimica Sintetica SA
Priority to DE60204721T priority patent/DE60204721T2/de
Priority to CA002467884A priority patent/CA2467884A1/en
Priority to ES02781546T priority patent/ES2243770T3/es
Priority to AU2002348926A priority patent/AU2002348926B2/en
Priority to PCT/IB2002/004828 priority patent/WO2003045961A1/en
Priority to JP2003547410A priority patent/JP2005510566A/ja
Priority to EP02781546A priority patent/EP1448576B1/en
Priority to AT02781546T priority patent/ATE297939T1/de
Priority to IL16206502A priority patent/IL162065A0/xx
Priority to US10/496,748 priority patent/US20050010054A1/en
Priority to NZ532923A priority patent/NZ532923A/en
Publication of ES2195752A1 publication Critical patent/ES2195752A1/es
Priority to ZA200403811A priority patent/ZA200403811B/en
Priority to IL162065A priority patent/IL162065A/en
Application granted granted Critical
Publication of ES2195752B1 publication Critical patent/ES2195752B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Procedimiento para la preparación de polimorfos cristalinos de la sal sódica del fosinopril.
Se describe un nuevo procedimiento para la preparación selectiva de los polimorfos cristalinos A y B del fosinopril, especialmente del polimorfo A.
El procedimiento descrito permite evitar el empleo de cantidades significativas de agua, lo que redunda en un riesgo menor de degradaciones hidrolíticas del principio activo.
ES200102739A 2001-11-30 2001-11-30 Procedimiento para la preparacion de polimorfos cristalinos de la sal sodica del fosinopril. Expired - Fee Related ES2195752B1 (es)

Priority Applications (14)

Application Number Priority Date Filing Date Title
ES200102739A ES2195752B1 (es) 2001-11-30 2001-11-30 Procedimiento para la preparacion de polimorfos cristalinos de la sal sodica del fosinopril.
US10/496,748 US20050010054A1 (en) 2001-11-30 2002-11-19 Preparation of crystalline polymorphs of fosinopril sodium
ES02781546T ES2243770T3 (es) 2001-11-30 2002-11-19 Preparacion de polimorfos cristalinos de fosinopril sodico.
AU2002348926A AU2002348926B2 (en) 2001-11-30 2002-11-19 Preparation of crystalline polymorphs of fosinopril sodium
PCT/IB2002/004828 WO2003045961A1 (en) 2001-11-30 2002-11-19 Preparation of crystalline polymorphs of fosinopril sodium
JP2003547410A JP2005510566A (ja) 2001-11-30 2002-11-19 フォシノプリルナトリウムの結晶性多形形態の製造
EP02781546A EP1448576B1 (en) 2001-11-30 2002-11-19 Preparation of crystalline polymorphs of fosinopril sodium
AT02781546T ATE297939T1 (de) 2001-11-30 2002-11-19 Herstellung von kristallinen polymorphen von fosinopril natrium
DE60204721T DE60204721T2 (de) 2001-11-30 2002-11-19 Herstellung von kristallinen polymorphen von fosinopril natrium
CA002467884A CA2467884A1 (en) 2001-11-30 2002-11-19 Preparation of crystalline polymorphs of fosinopril sodium
NZ532923A NZ532923A (en) 2001-11-30 2002-11-19 Selective preparation of crystalline polymorphs of sodium salt of fosinopril
IL16206502A IL162065A0 (en) 2001-11-30 2002-11-19 Preparation of crystalline polymorphs of fosinopril sodium
ZA200403811A ZA200403811B (en) 2001-11-30 2004-05-18 Preparation of crystalline polymorphs of fosinopril sodium.
IL162065A IL162065A (en) 2001-11-30 2004-05-19 Preparation of crystalline polymorphs of fosinopril sodium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200102739A ES2195752B1 (es) 2001-11-30 2001-11-30 Procedimiento para la preparacion de polimorfos cristalinos de la sal sodica del fosinopril.

Publications (2)

Publication Number Publication Date
ES2195752A1 ES2195752A1 (es) 2003-12-01
ES2195752B1 true ES2195752B1 (es) 2004-10-16

Family

ID=8499700

Family Applications (2)

Application Number Title Priority Date Filing Date
ES200102739A Expired - Fee Related ES2195752B1 (es) 2001-11-30 2001-11-30 Procedimiento para la preparacion de polimorfos cristalinos de la sal sodica del fosinopril.
ES02781546T Expired - Lifetime ES2243770T3 (es) 2001-11-30 2002-11-19 Preparacion de polimorfos cristalinos de fosinopril sodico.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES02781546T Expired - Lifetime ES2243770T3 (es) 2001-11-30 2002-11-19 Preparacion de polimorfos cristalinos de fosinopril sodico.

Country Status (12)

Country Link
US (1) US20050010054A1 (es)
EP (1) EP1448576B1 (es)
JP (1) JP2005510566A (es)
AT (1) ATE297939T1 (es)
AU (1) AU2002348926B2 (es)
CA (1) CA2467884A1 (es)
DE (1) DE60204721T2 (es)
ES (2) ES2195752B1 (es)
IL (2) IL162065A0 (es)
NZ (1) NZ532923A (es)
WO (1) WO2003045961A1 (es)
ZA (1) ZA200403811B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2041083T1 (sl) * 2006-05-26 2015-02-27 Generics (Uk) Limited Metode za pripravo zofenopril kalcija
CN107365268B (zh) * 2016-05-11 2021-02-05 常州制药厂有限公司 一种降压药福辛普利钠及其关键中间体的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162543A (en) * 1990-02-16 1992-11-10 E. R. Squibb & Sons, Inc. Selective processes for fosinopril polymorphs
WO2002088149A2 (en) * 2001-04-30 2002-11-07 Lupin Laboratories Limited A process for manufacture of fosinopril sodium

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BASE DE DATOS CA en STN, AN 120:62181 & BRITTAIN et al. "Solid-state NMR and IR for the analysis of pharmaceutical solids: polymorphs of fosinopril sodium" Journal of Pharmaceutical and Biomedical Analysis, Vol. 11, 1993, páginas 1063-1069. *

Also Published As

Publication number Publication date
ES2243770T3 (es) 2005-12-01
EP1448576A1 (en) 2004-08-25
WO2003045961A1 (en) 2003-06-05
AU2002348926A1 (en) 2003-06-10
JP2005510566A (ja) 2005-04-21
IL162065A0 (en) 2005-11-20
CA2467884A1 (en) 2003-06-05
US20050010054A1 (en) 2005-01-13
ZA200403811B (en) 2005-05-18
NZ532923A (en) 2005-11-25
IL162065A (en) 2007-10-31
DE60204721D1 (de) 2005-07-21
AU2002348926B2 (en) 2007-08-09
ES2195752A1 (es) 2003-12-01
EP1448576B1 (en) 2005-06-15
DE60204721T2 (de) 2006-05-18
ATE297939T1 (de) 2005-07-15

Similar Documents

Publication Publication Date Title
NO20063572L (no) Kinazolinditosylatsalt forbindelser
NO20023645D0 (no) Selektiv krystallisering av natrium 3-pyridyl-1- hydroksyetyliden-1,1-bisfosfonsyre som hemipentahydrat ellermonohydrat
HN1999000183A (es) Preparado farmaceuticos de moxifloxacina
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
EE200200710A (et) Asendatud bitsüklilised derivaadid ebanormaalse rakukasvu raviks
EE200300001A (et) Perindopriili tert-butüülamiinsoola kristallilinealfa-vorm
BR0115936A (pt) 2-anilino-benzimidazóis substituìdos e sua aplicação como inibidores de nhe
IS2019B (is) Nýtt kristallað form kalíumsalts (S)-ómeprasóls
PA8645701A1 (es) Procedimiento para producir derivados de amina opticamente activos
TR200200263T2 (tr) Yeni seçiçi retinoid agonistleri
ATE261440T1 (de) Pyridinsulfonylharnstoffderivate mit herbizider wirkung
BR0210912A (pt) Compostos e composições como inibidores de catepsina
BR0012291A (pt) Fenoxifluorpirimidinas
ES2191099T3 (es) Derivados de hidantoina como productos intermedios para principios activos farmaceuticos.
ATE525112T1 (de) Kombination aus flupirtin und tramadaol
ATE378335T1 (de) Chirale fluorochinolizinon arginine salze
ES2195752B1 (es) Procedimiento para la preparacion de polimorfos cristalinos de la sal sodica del fosinopril.
ATE325115T1 (de) Pyrimidinderivate als selektive cox-2-inhibitoren
UY26265A1 (es) Compuestos calciolíticos
ATE343576T1 (de) 7-azaindolderivate als cox2-inhibitoren
DE69828522D1 (de) Antithrombotische mittel
ATE405538T1 (de) Depigmentierungsmittel
NO20052562L (no) Anvendelse av distrontiumsalter av 2-[N,N-di(karboksylmetyl)amino]-3-cyano-4-karboksylmetyl-tiofen-5-karboksylsyre for fremstilling av medikamenter for behandlingen av gastro-duodenal smerte.
CA2512952A1 (en) Depigmentation agents
HN1999000115A (es) Derivados de imidoamida.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2195752B1

Country of ref document: ES

FD1A Patent lapsed

Effective date: 20100312